APA (7th ed.) Citation

Kaneko, S., Asahina, Y., Murakawa, M., Ueyama, S., Maeyashiki, C., Watanabe, H., . . . Inada, K. (2024). Prognostic significance of C‐reactive protein in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab. Hepatology Research, 54(6), 562. https://doi.org/10.1111/hepr.14001

Chicago Style (17th ed.) Citation

Kaneko, Shun, et al. "Prognostic Significance of C‐reactive Protein in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab." Hepatology Research 54, no. 6 (2024): 562. https://doi.org/10.1111/hepr.14001.

MLA (9th ed.) Citation

Kaneko, Shun, et al. "Prognostic Significance of C‐reactive Protein in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab and Bevacizumab." Hepatology Research, vol. 54, no. 6, 2024, p. 562, https://doi.org/10.1111/hepr.14001.